Chemours Q4 adjusted EPS $0.31 vs $0.00 YoY; full year net loss $238M on $764M litigation charges

Chemours Co

Q4 2023 net sales $1.4B (+2% YoY); full year net sales $6.0B (-11% YoY).
Q4 net loss $18M ($0.12 loss/diluted); adjusted net income $46M ($0.31 diluted EPS).
Full year net loss $238M ($1.60 loss/share); adjusted net income $425M ($2.82 EPS) vs $738M prior.
Adjusted EBITDA Q4 $176M vs $120M prior; full year $1.0B vs $1.4B, impacted by $89M/$764M litigation charges.
Segment: TT +7%, TSS +17%, APM -15%; CEO cites destocking and progress on legacy environmental matters.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Chemours Co reported fourth quarter and full year 2023 results: revenue Net Sales of $1.4 billion, net income Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share, EPS Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share.

Period: fourth quarter and full year 2023
Revenue: Net Sales of $1.4 billion
Net income: Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share
EPS: Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share
Result: reported results

Exact text from the filing

The Chemours Company Reports Fourth Quarter and Full Year 2023 Results Wilmington, Del., March 27, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the fourth quarter and full year 2023. Key Fourth Quarter 2023 Results • Net Sales of $1.4 billion, up 2% year-over-year • Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share

View on SEC.gov

326 earnings releases filed in the last 30 days. Browse all earnings releases →

Chemours Co filing history →

Source: SEC EDGAR

accession 0000950170-24-037412

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.